FDA approves Guardant Well being’s blood take a look at for colon most cancers


Shares of Guardant Well being (GH) rose after the US Meals and Drug Administration authorised the corporate’s blood take a look at to display for colorectal most cancers in some adults. It is the primary such take a look at to get approval.

Market Domination anchors Julie Hyman and Josh Lipton focus on the approval within the video above.

For extra knowledgeable perception and the most recent market motion, click on right here to look at this full episode of Market Domination.

This publish was written by Stephanie Mikulich.

Hot Topics

Related Articles